Cargando…
Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses
Vaccines based on recombinant proteins avoid toxicity and anti-vector immunity associated with live vaccine (e.g., viral) vectors, but their immunogenicity is poor, particularly for CD8(+) T-cell (CD8T) responses. Synthetic particles carrying antigens and adjuvant molecules have been developed to en...
Autores principales: | Moon, James J., Suh, Heikyung, Bershteyn, Anna, Stephan, Matthias T., Liu, Haipeng, Huang, Bonnie, Sohail, Mashaal, Luo, Samantha, Um, Soong Ho, Khant, Htet, Goodwin, Jessica T., Ramos, Jenelyn, Chiu, Wah, Irvine, Darrell J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077947/ https://www.ncbi.nlm.nih.gov/pubmed/21336265 http://dx.doi.org/10.1038/nmat2960 |
Ejemplares similares
-
Supramolecular zippers elicit interbilayer adhesion of membranes producing cell death
por: Almendro-Vedia, Víctor G., et al.
Publicado: (2018) -
Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
por: Liu, Yarong, et al.
Publicado: (2014) -
Therapeutic cell engineering using surface-conjugated synthetic
nanoparticles
por: Stephan, Matthias T., et al.
Publicado: (2010) -
Formulation and evaluation of multilamellar vesicles ropivacaine in pain management
por: Kao, Hao-Wen, et al.
Publicado: (2019) -
Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
por: Zhang, Yuan, et al.
Publicado: (2018)